EMA

欧洲药品管理局（European Medicines Agency，EMA）成立于1995年的欧洲药品管理局，欧洲药品管理局负责泛欧洲范围的药品审批。

共 33 讨论,7天新增 28 个讨论,30天新增 28 个讨论

综合 问题 文章 百科
最新排序
热门排序
推荐内容
kk444555kk444555 回复了问题 2023-10-17 22:49
EMA
问答 What are the requirements for conducting visual inspection as per Q&A 7?
kk444555: When applying visual inspection to determine cleanliness of equipment, manufacturers should establish the threshold at which the product is readily vi...
kk444555kk444555 回复了问题 2023-10-17 22:47
EMA
问答 清洁验证完成之后，共用设施里的设备中更换产品时是否需要进行分析检测？
kk444555: Analytical testing is expected at each changeover unless justified otherwise via a robust, documented Quality Risk Management (QRM) process. The QRM p...
kk444555kk444555 回复了问题 2023-10-17 22:46
EMA
问答 How can limits for cleaning purposes be established?
kk444555: Although the EMA guideline (EMA/CHMP/CVMP/SWP/169430/2012) may be used to justify cleaning limits (as per Introduction paragraph 3), it is not intende...
kk444555kk444555 回复了问题 2023-10-17 22:45
EMA
问答 委托生产方在支持HBEL评估的数据方面有什么职责？
kk444555: Contract givers should either provide a full HBEL assessment to contract manufacturers or provide the data to allow the contract manufacturer to condu...
kk444555kk444555 回复了问题 2023-10-17 22:44
EMA
问答 What competencies are required for the person developing the Health-Based Exposure Limits (HBEL)?
kk444555: Health-Based Exposure Limits should be determined by a person who has adequate expertise and experience in toxicology/pharmacology, familiarity with p...
kk444555kk444555 回复了问题 2023-10-17 22:43
EMA
问答 How should manufacturers use the HBELs?
kk444555: The role of HBELs in determining cleaning limits is explained in Q&A 6. However, the purpose of generating HBELs goes beyond justification of clea...
kk444555kk444555 回复了问题 2023-10-17 22:42
EMA
问答 有什么框架可以用来确定HBEL，用以广泛指导质量风险管理（QRM）的程度和是否需要控制措施？
kk444555: Firstly, it should be recognised that hazard varies on a continuum scale and that there are no firm cut off points, risk should be controlled on a pro...
kk444555kk444555 回复了问题 2023-10-17 22:41
EMA
问答 Are Health-Based Exposure Limits (HBELs) required for all medicinal products?
kk444555: Yes, HBELs should be established for all medicinal products. The toxicological or pharmacological data, on which the HBEL calculation relies, requires...
kk444555kk444555 回复了问题 2023-10-17 22:40
EMA
问答 生产过程中使用的设备变更，公司质量保证体系 (GMP) 涵盖哪些变更？
kk444555: Provided thatthe new equipment isequivalent to the one currently used, and operates in theapproved range ofprocess parameters, the change is covered b...
kk444555kk444555 回复了问题 2023-10-17 22:39
EMA
问答 生产基地、厂房和房间的哪些变更可以由公司质量保证体系 (GMP) 覆盖？
kk444555: Provided thatmodule 3 is not impacted, withthe exception of section 3.2.A.1 (forbiological medicinalproducts), the changeslisted below (not an exhaust...
kk444555kk444555 回复了问题 2023-10-17 22:33
EMA
问答 如果原料药生产的发酵工艺中使用了蛋白胨（例如动物和植物来源），是否需要放在相关注册资料中？
kk444555: Yes. Peptone is considered to be a critical raw material, whose origin (animal or vegetable) and source (supplier name and address) should be specifie...
kk444555kk444555 回复了问题 2023-10-17 22:31
EMA
问答 在发酵过程中，生产活性物质所使用的任何蛋白胨(如动物或植物来源)的来源是否必须列入相关档案？
kk444555: Yes.Peptone is considered to be a critical raw material, whose origin (animal orvegetable) and source (supplier name and address) should be specified ...
kk444555kk444555 回复了问题 2023-10-17 22:31
EMA
问答 活性物质标准是否需要明确在生产过程中使用了鱼蛋白胨，并且组胺是控制在协定范围内的特定杂质？
kk444555: Yes.If fish peptone is used in the fermentation process there is a potentialserious risk to public health if it is contaminated with high levels ofhis...
文章 知识分享|EMA药品、活性物质、辅料和内包装灭菌指南翻译与解读（四）
知识分享|EMA药品、活性物质、辅料和内包装灭菌指南翻译与解读（四）
6. Definitions 名词解释Aseptic processing无菌工艺一种用于保持由各种经过蒸汽、干热、电离辐射、气体或除菌过滤的方式进行了灭菌的部件组合而成的产品的无菌性的工艺。这种工艺是通过使用旨在防止微生物污染物...
指南 制药 EMA
文章 知识分享|EMA药品、活性物质、辅料和内包装灭菌指南翻译与解读（三）
知识分享|EMA药品、活性物质、辅料和内包装灭菌指南翻译与解读（三）
4.1.6. Aseptic processing 无菌工艺Aseptic processing is not considered to be a sterilisation process but concerns the u...
指南 制药 EMA
发讨论
写文章
话题日志

相关话题

父话题
质量机构

3 人关注该话题

热门话题

ESG

质量角色

NOM认证

CNAS

无源医疗器械

技术支持 WeCenter © 2024 粤ICP备2023143277号-1